264 related articles for article (PubMed ID: 33462260)
21. Unique metastasis-associated lncRNA signature optimizes prediction of tumor relapse in lung adenocarcinoma.
Zhang X; Han J; Du L; Li X; Hao J; Wang L; Zheng G; Duan W; Xie Y; Zhao Y; Zhang X; Zou M; Wang C
Thorac Cancer; 2020 Mar; 11(3):728-737. PubMed ID: 31994347
[TBL] [Abstract][Full Text] [Related]
22. Identification of a Four-Gene Signature Associated with the Prognosis Prediction of Lung Adenocarcinoma Based on Integrated Bioinformatics Analysis.
Wu Y; Yang L; Zhang L; Zheng X; Xu H; Wang K; Weng X
Genes (Basel); 2022 Jan; 13(2):. PubMed ID: 35205284
[TBL] [Abstract][Full Text] [Related]
23. Mast cell-based molecular subtypes and signature associated with clinical outcome in early-stage lung adenocarcinoma.
Bao X; Shi R; Zhao T; Wang Y
Mol Oncol; 2020 May; 14(5):917-932. PubMed ID: 32175651
[TBL] [Abstract][Full Text] [Related]
24. Construction of the optimization prognostic model based on differentially expressed immune genes of lung adenocarcinoma.
Zhai Y; Zhao B; Wang Y; Li L; Li J; Li X; Chang L; Chen Q; Liao Z
BMC Cancer; 2021 Mar; 21(1):213. PubMed ID: 33648465
[TBL] [Abstract][Full Text] [Related]
25. Characteristic of molecular subtypes in lung adenocarcinoma based on m6A RNA methylation modification and immune microenvironment.
Zhou H; Zheng M; Shi M; Wang J; Huang Z; Zhang H; Zhou Y; Shi J
BMC Cancer; 2021 Aug; 21(1):938. PubMed ID: 34416861
[TBL] [Abstract][Full Text] [Related]
26. Identification of a TGF-β signaling-related gene signature for prediction of immunotherapy and targeted therapy for lung adenocarcinoma.
Yu Q; Zhao L; Yan XX; Li Y; Chen XY; Hu XH; Bu Q; Lv XP
World J Surg Oncol; 2022 Jun; 20(1):183. PubMed ID: 35668494
[TBL] [Abstract][Full Text] [Related]
27. Hypoxia-related gene signature for predicting LUAD patients' prognosis and immune microenvironment.
Chen J; Fu Y; Hu J; He J
Cytokine; 2022 Apr; 152():155820. PubMed ID: 35176657
[TBL] [Abstract][Full Text] [Related]
28. Construction of a Redox-Related Prognostic Model with Predictive Value in Survival and Therapeutic Response for Patients with Lung Adenocarcinoma.
Xiao L; Li Q; Huang Y; Fan Z; Ma L; Liu B; Yuan X
J Healthc Eng; 2022; 2022():7651758. PubMed ID: 35251577
[TBL] [Abstract][Full Text] [Related]
29. Genome‑wide investigation of the clinical significance and prospective molecular mechanisms of kinesin family member genes in patients with lung adenocarcinoma.
Zhang L; Zhu G; Wang X; Liao X; Huang R; Huang C; Huang P; Zhang J; Wang P
Oncol Rep; 2019 Sep; 42(3):1017-1034. PubMed ID: 31322267
[TBL] [Abstract][Full Text] [Related]
30. A ten-gene signature-based risk assessment model predicts the prognosis of lung adenocarcinoma.
Jiang H; Xu S; Chen C
BMC Cancer; 2020 Aug; 20(1):782. PubMed ID: 32819300
[TBL] [Abstract][Full Text] [Related]
31. A Prognostic 14-Gene Expression Signature for Lung Adenocarcinoma: A Study Based on TCGA Data Mining.
Liu J; Hou S; Wang J; Chai Z; Hong X; Zhao T; Sun Z; Bai L; Gao H; Gao J; Chen G
Oxid Med Cell Longev; 2020; 2020():8847226. PubMed ID: 33414898
[TBL] [Abstract][Full Text] [Related]
32. Identification and Validation of a Proliferation-Associated Score Model Predicting Survival in Lung Adenocarcinomas.
Bian Y; Sui Q; Bi G; Zheng Y; Zhao M; Yao G; Xue L; Zhang Y; Fan H
Dis Markers; 2021; 2021():3219594. PubMed ID: 34721732
[TBL] [Abstract][Full Text] [Related]
33. Identification of 4 immune cells and a 5-lncRNA risk signature with prognosis for early-stage lung adenocarcinoma.
Mu L; Ding K; Tu R; Yang W
J Transl Med; 2021 Mar; 19(1):127. PubMed ID: 33771173
[TBL] [Abstract][Full Text] [Related]
34. Systematic construction and validation of an immune prognostic model for lung adenocarcinoma.
Luo C; Lei M; Zhang Y; Zhang Q; Li L; Lian J; Liu S; Wang L; Pi G; Zhang Y
J Cell Mol Med; 2020 Jan; 24(2):1233-1244. PubMed ID: 31779055
[TBL] [Abstract][Full Text] [Related]
35. Seven interferon gamma response genes serve as a prognostic risk signature that correlates with immune infiltration in lung adenocarcinoma.
Yao B; Wang L; Wang H; Bao J; Li Q; Yu F; Zhu W; Zhang L; Li W; Gu Z; Fei K; Zhang P; Zhang F; Huang X
Aging (Albany NY); 2021 Apr; 13(8):11381-11410. PubMed ID: 33839701
[TBL] [Abstract][Full Text] [Related]
36. An ICD-Associated DAMP Gene signature predicts survival and immunotherapy response of patients with lung adenocarcinoma.
Wu Y; Li K; Liang S; Lou X; Li Y; Xu D; Wu Y; Wang Y; Cui W
Respir Res; 2023 May; 24(1):142. PubMed ID: 37259066
[TBL] [Abstract][Full Text] [Related]
37. Identification of a 7-miRNA signature for predicting the prognosis of patients with lung adenocarcinoma.
Liu R; Guo Z; Huang J; Li J; Tan Q; Luo Q
Exp Biol Med (Maywood); 2022 Apr; 247(8):641-657. PubMed ID: 35068222
[TBL] [Abstract][Full Text] [Related]
38. Establishment and validation of an eight-gene metabolic-related prognostic signature model for lung adenocarcinoma.
Ma W; Liang J; Liu J; Tian D; Chen Z
Aging (Albany NY); 2021 Feb; 13(6):8688-8705. PubMed ID: 33619235
[TBL] [Abstract][Full Text] [Related]
39. Gene signature based on B cell predicts clinical outcome of radiotherapy and immunotherapy for patients with lung adenocarcinoma.
Han L; Shi H; Luo Y; Sun W; Li S; Zhang N; Jiang X; Gong Y; Xie C
Cancer Med; 2020 Dec; 9(24):9581-9594. PubMed ID: 33098370
[TBL] [Abstract][Full Text] [Related]
40. A novel gene expression signature-based on B-cell proportion to predict prognosis of patients with lung adenocarcinoma.
Zhang Y; Yin X; Wang Q; Song X; Xia W; Mao Q; Chen B; Liang Y; Zhang T; Xu L; Jiang F; Xu X; Dong G
BMC Cancer; 2021 Oct; 21(1):1098. PubMed ID: 34641822
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]